Long-Fiber Carbon Nanotubes Replicate Asbestos-Induced Mesothelioma with Disruption of the Tumor Suppressor Gene Cdkn2a (Ink4a/Arf)

被引:84
|
作者
Chernova, Tatyana [1 ]
Murphy, Fiona A. [1 ]
Galavotti, Sara [1 ]
Sun, Xiao-Ming [1 ]
Powley, Ian R. [1 ]
Grosso, Stefano [1 ]
Schinwald, Anja [2 ]
Zacarias-Cabeza, Joaquin [1 ]
Dudek, Kate M. [1 ]
Dinsdale, David [1 ]
Le Quesne, John [1 ,3 ]
Bennett, Jonathan [3 ]
Nakas, Apostolos [3 ]
Greaves, Peter [4 ]
Poland, Craig A. [2 ]
Donaldson, Ken [2 ]
Bushell, Martin [1 ]
Willis, Anne E. [1 ]
MacFarlane, Marion [1 ]
机构
[1] Med Res Council Toxicol Unit, Hodgkin Bldg,POB 138,Lancaster Rd, Leicester LE1 9HN, Leics, England
[2] Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, Med Res Council, Edinburgh EH16 4TJ, Midlothian, Scotland
[3] Glenfield Hosp, Univ Hosp Leicester NHS Trust, Leicester LE3 9QP, Leics, England
[4] Univ Leicester, Dept Canc Studies, Leicester LE2 7LX, Leics, England
基金
英国医学研究理事会;
关键词
MALIGNANT PLEURAL MESOTHELIOMA; INTRAPERITONEAL INJECTION; INDUCED MURINE; FOLLOW-UP; INFLAMMATION; CANCER; METHYLATION; MICE; CARCINOGENESIS; PATHOGENICITY;
D O I
10.1016/j.cub.2017.09.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mesothelioma is a fatal tumor of the pleura and is strongly associated with asbestos exposure. The molecular mechanisms underlying the long latency period of mesothelioma and driving carcinogenesis are unknown. Moreover, late diagnosis means that mesothelioma research is commonly focused on end-stage disease. Although disruption of the CDKN2A (INK4A/ARF) locus has been reported in end-stage disease, information is lacking on the status of this key tumor suppressor gene in pleural lesions preceding mesothelioma. Manufactured carbon nanotubes (CNTs) are similar to asbestos in terms of their fibrous shape and biopersistent properties and thus may pose an asbestos-like inhalation hazard. Here we show that instillation of either long CNTs or long asbestos fibers into the pleural cavity of mice induces mesothelioma that exhibits common key pro-oncogenic molecular events throughout the latency period of disease progression. Sustained activation of pro-oncogenic signaling pathways, increased proliferation, and oxidative DNA damage form a common molecular signature of long-CNT- and long-asbestos-fiber-induced pathology. We show that hypermethylation of p16/Ink4a and p19/Arf in CNT- and asbestos-induced inflammatory lesions precedes mesothelioma; this results in silencing of Cdkn2a (Ink4a/Arf) and loss of p16 and p19 protein, consistent with epigenetic alterations playing a gatekeeper role in cancer. In end-stage mesothelioma, silencing of p16/Ink4a is sustained and deletion of p19/Arf is detected, recapitulating human disease. This study addresses the long-standing question of which early molecular changes drive carcinogenesis during the long latency period of mesothelioma development and shows that CNT- and asbestos pose a similar health hazard.
引用
收藏
页码:3302 / +
页数:19
相关论文
共 22 条
  • [1] Loss of Ink4a and Arf each contributes to increased susceptibility to asbestos-induced malignant mesothelioma development
    Altomare, Deborah A.
    Menges, Craig W.
    Xu, Jinfei
    Pei, Jianming
    Zhang, Lili
    Tadevosyan, Ara
    Neumann-Domer, Erin
    Liu, Zemin
    Carbone, Michele
    Chudoba, Ilse
    Klein-Szanto, Andres J.
    Testa, Joseph R.
    CANCER RESEARCH, 2011, 71
  • [2] Losses of Both Products of the Cdkn2a/Arf Locus Contribute to Asbestos-Induced Mesothelioma Development and Cooperate to Accelerate Tumorigenesis
    Altomare, Deborah A.
    Menges, Craig W.
    Xu, Jinfei
    Pei, Jianming
    Zhang, Lili
    Tadevosyan, Ara
    Neumann-Domer, Erin
    Liu, Zemin
    Carbone, Michele
    Chudoba, Ilse
    Klein-Szanto, Andres J.
    Testa, Joseph R.
    PLOS ONE, 2011, 6 (04):
  • [3] Alterations in the p16INK4a/CDKN2A tumor suppressor gene in gastrinomas
    Serrano, J
    Goebel, SU
    Peghini, PL
    Lubensky, IA
    Gibril, F
    Jensen, RT
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11): : 4146 - 4156
  • [4] Altered microRNA Expression Profiles and Regulation of INK4A/CDKN2A Tumor Suppressor Genes in Canine Breast Cancer Models
    Kabir, Farruk Mohammad Lutful
    DeInnocentes, Patricia
    Bird, Richard Curtis
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2015, 116 (12) : 2956 - 2969
  • [5] Regulation of Tumor Suppressor Gene CDKN2A and Encoded p16-INK4a Protein by Covalent Modifications
    Jiao, Yang
    Feng, Yunpeng
    Wang, Xiuli
    BIOCHEMISTRY-MOSCOW, 2018, 83 (11) : 1289 - 1298
  • [6] Genetic alterations of gastrinomas:: An analysis of p16INK4A/CDKN2A tumor suppressor gene.
    Serrano, J
    Goebel, S
    Jensen, RT
    GASTROENTEROLOGY, 1999, 116 (04) : A501 - A501
  • [7] Regulation of Tumor Suppressor Gene CDKN2A and Encoded p16-INK4a Protein by Covalent Modifications
    Yang Jiao
    Yunpeng Feng
    Xiuli Wang
    Biochemistry (Moscow), 2018, 83 : 1289 - 1298
  • [8] The p16/Cdkn2a/Ink4a gene is frequently deleted in nitrosourea-induced rat glial tumors
    Schlegel, J
    Piontek, G
    Kersting, M
    Schuermann, M
    Kappler, R
    Scherthan, H
    Weghorst, C
    Buzard, G
    Mennel, HD
    PATHOBIOLOGY, 1999, 67 (04) : 202 - 206
  • [9] Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL
    Mullighan, Charles G.
    Williams, Richard T.
    Downing, James R.
    Sherr, Charles J.
    GENES & DEVELOPMENT, 2008, 22 (11) : 1411 - 1415
  • [10] The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: A promoter methylation and protein expression study in 100 cases
    Ai, LB
    Stephenson, KK
    Ling, WH
    Zuo, CL
    Mukunyadzi, P
    Suen, JY
    Hanna, E
    Fan, CY
    MODERN PATHOLOGY, 2003, 16 (09) : 944 - 950